• ABT-888 (Veliparib): Advanced PARP Inhibition in MSI Tumor M

  2026-04-21

  Explore the unique mechanisms of ABT-888 (Veliparib) as a potent PARP inhibitor, with an in-depth analysis of its role in DNA repair inhibition and combination therapies for microsatellite instability (MSI) tumor models. Discover differentiated insights, protocol guidance, and the latest scientific findings.

• HyperScript™ Reverse Transcriptase: Unraveling RNA Complexit

  2026-04-20

  Explore how HyperScript™ Reverse Transcriptase empowers precise cDNA synthesis for qPCR, especially in the context of endoplasmic reticulum (ER) stress and complex RNA templates. This article uniquely bridges advanced enzyme technology with cutting-edge stem cell research.

• Coumestrol Induces Ferroptosis in RA Synoviocytes via PMAIP1

  2026-04-20

  This study demonstrates that Coumestrol, a phytoestrogen estrogen receptor antagonist, induces ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes by stabilizing mitochondrial PMAIP1 through TRIM3 inhibition. The findings reveal a novel mechanism for suppressing synovial proliferation and inflammation, highlighting Coumestrol’s promise as a candidate for targeted RA therapies.

• Peptidisc-Enabled Nanobody Multimerization for Polybody Engi

  2026-04-19

  Chen and Duong van Hoa present a peptidisc-assisted strategy for hydrophobic clustering, enabling the assembly of multimeric and multispecific nanobody proteins ('polybodies'). This approach enhances nanobody affinity and versatility, expanding the protein engineering toolkit for advanced biochemical applications.

• Ferritin-Based Hybrid Protein Particles for Combination Vacc

  2026-04-18

  This study introduces a ferritin-based hybrid protein particle vaccine integrating influenza A M2e and SARS-CoV-2 S-protein epitopes into a single nanostructure. The approach enables simultaneous multivalent antigen display and enhances immunogenicity, offering a scalable route to combination vaccine development with robust functional responses.

• Thrombin as a Trypsin-like Serine Protease: Applied Protocol

  2026-04-17

  Unlock the full experimental power of thrombin in coagulation, vascular modeling, and platelet research. This guide details advanced workflows, troubleshooting strategies, and comparative protocol enhancements using APExBIO’s high-purity Coagulation Factor II (Thrombin) B Chain Fragment.

• Bazedoxifene Inhibits IL-6/GP130 Signaling: Implications for

  2026-04-16

  This review highlights bazedoxifene's novel role as an IL-6/GP130 pathway inhibitor in multiple cancer models, expanding its clinical potential beyond osteoporosis. The paper synthesizes evidence for bazedoxifene’s direct interference in pro-tumorigenic signaling and examines its impact on tumor progression and synergy with established chemotherapeutics.

• Targeting FGFR2 Fusions in ICC via Heteroduplex Oligonucleot

  2026-04-15

  This study introduces a cholesterol-conjugated DNA/RNA heteroduplex oligonucleotide (Cho-HDO) that specifically suppresses FGFR2 fusion oncogenes in intrahepatic cholangiocarcinoma (ICC), revealing a mechanism of resistance involving asparagine metabolism. The findings lay groundwork for combinatorial therapies targeting both FGFR2 fusions and metabolic adaptation, with implications for the precision treatment of ICC.

• Bismuth Subsalicylate: Protocols for GI Disorder Research

  2026-04-14

  Bismuth Subsalicylate is a high-purity solid compound tailored for inflammation pathway modulation and gastrointestinal disorder research. It is best suited for experimental models investigating diarrhea or upset stomach symptom relief where robust inhibition of prostaglandin G/H synthase 1/2 is required. This reagent should not be used in diagnostic or clinical workflows, and special care must be taken with solubility and storage.

• Dissecting In Vitro Drug Response Metrics in Cancer Research

  2026-04-13

  Schwartz's dissertation redefines in vitro drug response evaluation by clarifying the distinction and interplay between relative and fractional viability metrics. This work provides methodological guidance for interpreting anti-cancer compound effects on proliferation and cell death, with implications for assay design and translational cancer biology.

• Monomeric Amyloid Beta Signaling Modulates Microglia in Brai

  2026-04-13

  A recent eLife study reveals that monomeric amyloid beta activates a novel signaling pathway that inhibits microglial activation, thereby influencing mouse neocortical development. These findings challenge the traditional view of amyloid beta solely as a pathological agent in Alzheimer's disease and suggest a physiological role for monomeric forms in brain maturation.

• Dabigatran in Anticoagulation Research: Applied Workflows &

  2026-04-12

  Dabigatran (Pradaxa) empowers researchers with precision thrombin inhibition for robust coagulation studies, translational stroke prevention models, and reliable therapeutic development. Explore stepwise protocols, advanced applications, and troubleshooting strategies that maximize reproducibility and sensitivity with APExBIO’s validated Dabigatran.

• Proteinase K: Broad-Spectrum Serine Protease for DNA Prep Ex

  2026-04-12

  Proteinase K from APExBIO empowers genomic DNA workflows with robust protein hydrolysis and unmatched contaminant removal, safeguarding DNA integrity. This guide details evidence-based protocols, advanced troubleshooting, and reference-driven innovation for optimal results in molecular biology.

• NHS-Biotin: Precision Biotinylation for Advanced Protein Eng

  2026-04-11

  NHS-Biotin empowers researchers to achieve site-specific, membrane-permeable labeling of antibodies and proteins, streamlining purification and detection workflows. This article translates cutting-edge multimeric protein research into actionable protocols and troubleshooting strategies, spotlighting the unique advantages of APExBIO's NHS-Biotin.

• HyperScribe T7 High Yield RNA Synthesis Kit: Optimizing In V

  2026-04-11

  The HyperScribe™ T7 High Yield RNA Synthesis Kit from APExBIO offers a robust platform for producing high-quality, functional RNAs—essential for cutting-edge applications like RNA vaccine research and mechanistic studies of cellular stress pathways. This guide explores experimental tips, protocol optimization, and critical insights inspired by recent advances in disc degeneration research, empowering scientists to troubleshoot and scale their T7 RNA polymerase transcription strategies.

16712 records 1/1115 page Next 12345 下5页 Last page